EPO Standards: One vial, 5 mL, labeled A, containing of 0 mIU/mL human EPO and six vials, 1 mL each, labeled B-G, containing concentrations of approximately 5, 10, 25, 50, 100 and 200 mIU/mL human EPO in a protein-based buffer with sodium azide as a preservative.EPO [I-125] Reagent: One vial, 11 mL, containing < 5 μCi (185 kBq) of [I-125]-labeled EPO in a protein-based buffer with sodium azide as a preservative. EPO Antiserum: One vial, containing rabbit anti-human EPO serum in a protein-based buffer with sodium azide as a preservative.Precipitating Reagent: One bottle, 100 mL, containing goat anti-rabbit gamma globulin serum in a buffer with polyethylene glycol as a precipitating aid and sodium azide as a preservative.EPO Controls: Two vials, 1 mL each, containing low and high concentrations of human EPO in a protein-based buffer with sodium azide as a preservative.
共有 1 個藥物證書使用此成份
- 申請商
- 常盈實業股份有限公司
- 適應症
- 含量
- 發證日期
- 2006-01-17